- Nā lāʻau lapaʻau
- Nā Hōʻike Manaʻo
- ʻO ka Neuroblastoma
- Puʻupuʻu paʻa
- Nā Hōʻike Manaʻo
- TILS
- NK Cell Therapy
- ʻO ka Myasthenia Gravis (MG)
- ʻO ka maʻi leukemia lymphoblastic koʻikoʻi (B-ALL)
- ʻO ka Lupus Erythematosus Pūnaehana (SLE)
- ʻO ka maʻi leukemia lymphoblastic koʻikoʻi (T-ALL)
- ʻO ka Lymphoma Non-Hodgkin (NHL)
- ʻO ka Myeloma Nui (MM)
- ʻO ka Lymphom cell B nui e hoʻolaha ʻia
- ʻO ka maʻi leukemia lymphocytic B
- Myeloma
CAR-T no ka maʻi ʻaʻai hepatocellular
-
Kelepona CAR-T
CAR-T (Chimeric Antigen Receptor T-cell) ʻO ka lāʻau lapaʻau he immunotherapy e kū mai ana e hoʻololi i kāu mau pūnaewele T ponoʻī e ʻike maikaʻi a luku i nā hunaola kanesa. No HCC, kuhikuhi kēia lāʻau lapaʻau i nā protein kikoʻī ma nā hunaola tumor, hiki ke hāʻawi i kahi mea hou aku koho ʻē aʻe pololei a i ʻole hoʻokō i nā lāʻau lapaʻau maʻamau.
Hoʻokomo ia i ka hōʻiliʻili ʻana a me ka hana ʻenekinia ʻana i kāu mau hunaola pale ma kahi keʻena hoʻokolohua ma mua o ka hoʻokomo hou ʻana iā lākou, me ka manaʻo e hoʻokō nā pane paʻa me nā hopena ʻaoʻao ʻōnaehana liʻiliʻi.
Nā Pahuhopu ma ka Lapaʻau CAR-T no ka Hepatocellular Carcinoma
ʻO Glypican-3 (GPC3) he pahuhopu koʻikoʻi no ka lāʻau lapaʻau CAR-T ma HCC ma muli o kona hōʻike kiʻekiʻe ʻana ma nā hunaola kanesa o ke akepaʻa a me ka liʻiliʻi o ka ʻike ʻana i nā ʻiʻo pākeke olakino.
ʻO GPC3 kahi protein ʻili pūnaewele e paipai ana i ka ulu ʻana o ka puʻupuʻu ma o ka hoʻoikaika ʻana i nā ala hōʻailona e like me Wnt, kahi e hoʻoulu ai i ka hoʻonui ʻana o ka maʻi kanesa. Ma ke kuhikuhi ʻana i nā pūnaewele CAR-T e hoʻopaʻa iā GPC3, hoʻoikaika ka lāʻau lapaʻau i nā hoʻouka kaua ʻana ma nā pūnaewele ʻino, e mālama ana i ka hana maʻamau o ke akepaʻa e like me ka hiki. He mea kūpono loa kēia hoʻolālā i hoʻolālā ʻia no nā poʻe maʻi me ka HCC holomua i pane ʻole i nā lāʻau lapaʻau mua.
Pehea e hana ai ka CAR-T Therapy: Ke ʻano hana
Ua hoʻolālā ʻia ke kaʻina hana o ka CAR-T therapy e hoʻohana a hoʻonui i nā pale kūlohelohe o kou kino:
- HōʻiliʻiliLoaʻa kahi hāpana o kāu mau pūnaewele T ma o ke kaʻina hana maʻalahi e like me ke kaha koko.
- ʻenekiniaI loko o ka hale hana hoʻokolohua, ua hoʻololi ʻia kēia mau pūnaewele T i ka genetics e hōʻike i kahi chimeric antigen receptor (CAR) e ʻike pono ana iā GPC3 ma nā pūnaewele HCC.
- Hoʻāla a me ka Hoʻonui ʻanaHoʻoulu ʻia nā pūnaewele i hoʻololi ʻia i nā helu he nui a hoʻāla ʻia e lilo i mau mea hakakā kanesa ikaika.
- Hoʻokomo ʻanaHoʻihoʻi ʻia nā pūnaewele CAR-T i loko o kou kahe koko, kahi e ʻimi ai a hoʻopaʻa i nā pūnaewele tumo e hōʻike ana i ka GPC3.
- HoʻoukaMa ke nakinaki ʻana, hoʻokuʻu nā pūnaewele CAR-T i nā hōʻailona e luku i nā pūnaewele kanesa, e alakaʻi paha i ka hōʻemi ʻana o ka puʻupuʻu a me ka nānā mau ʻana i ka pale ʻana.
ʻO ka pahuhopu o kēia ʻano hana ke hāʻawi i kahi pane mau, ʻoiai he mea nui ka nānā pono ʻana e hoʻokele i nā hopena e pili ana i ka pale ʻana.
ʻO ka lāʻau lapaʻau CAR-T i kuhikuhi ʻia e GPC3 no ka maʻi hepatocellular carcinoma hōʻike i ka hopena ikaika i nā hoʻokolohua lapaʻau. I kā mākou noiʻi ʻana i 30 mau maʻi me ka GPC3-positive HCC holomua i hāʻule i nā lāʻau lapaʻau mua, ʻo ka ʻo ka helu pane kūʻokoʻa he 56.6%, me 53.3% nā pane hapa. Ua hōʻea ka helu kaohi maʻi 86.7%, me ka waena ke ola ʻole me ka holomua ʻole o 13 mau mahina a me ʻO ke ola holoʻokoʻa he 14.6 mau mahina. He palekana ka lāʻau lapaʻau, me ka cytokine release syndrome liʻiliʻi a me nā hopena ʻaoʻao e hiki ke hoʻokele. Ke hoʻomau nei mākou i ka hoʻokele ʻana i kēia mau lāʻau lapaʻau e hoʻonui i nā hopena no nā poʻe maʻi kanesa o ke akepaʻa.
ʻO ka Radiotherapy Kino Stereotactic (SBRT)
Hoʻopili kēia ʻano hana radiation pololei i nā ʻōpū ate liʻiliʻi me nā dosis kiʻekiʻe i loko o kekahi mau kau, e hōʻemi ana i ka nui o ka ʻōpū a hoʻonui paha i ka infiltration o nā cell CAR-T me ka hoʻemi ʻana i ka hōʻino ʻana i nā ʻiʻo ate a puni.
Hoʻopau ʻana i ke komo ʻana
ʻO nā kaʻina hana minimally invasive e like me ka radiofrequency a i ʻole ka microwave ablation e hoʻopau i nā ʻiʻo tumor ma o ka wela, e hana ana i kahi wahi e hiki ai i nā pūnaewele CAR-T ke hoʻopaʻa pono i nā cell cancer i koe.
ʻO ka Chemoembolization Transarterial (TACE)
Ma ka hāʻawi pololei ʻana i ka chemotherapy i ka puʻupuʻu ma o ke aʻa hepatic a me ke ālai ʻana i kona lako koko, hoʻēmi ʻo TACE i nā puʻupuʻu a hiki ke hana pū me CAR-T ma ka hoʻonāwaliwali ʻana i nā pale kaua kanesa a me ka hoʻomaikaʻi ʻana i ka pane pale.
ʻoki kino
No nā poʻe maʻi kūpono, hiki i ka ʻoki ʻāpana o ke akepaʻa ke wehe i ka maʻi nui, e ʻae ana iā CAR-T e kālele i nā koena microscopic.
ʻO ka pahuhopu o kēia mau hui pū ʻana e hoʻonui i nā hopena me ka hoʻoikaika ʻana i kou ʻoluʻolu a me ke olakino o ke ake.
Nā Nīnau i Nīnau Pinepine ʻia
- He kūpono anei ka lāʻau lapaʻau CAR-T no nā poʻe maʻi HCC āpau? Manaʻo pinepine ʻia no ka poʻe me nā puʻupuʻu GPC3-positive i holomua ma nā ʻano lapaʻau maʻamau. ʻO kahi loiloi piha, me ka hoʻāʻo ʻana i ka biomarker, e hoʻoholo ai i ke kūpono.
- He aha nā hopena ʻaoʻao e hiki iaʻu ke ʻike? ʻO nā mea maʻamau e komo pū me nā hōʻailona like me ka maʻi palū mai CRS, luhi, a i ʻole nā loli hana ate no ka manawa pōkole, kahi i nānā ʻia a mālama koke ʻia.
- Pehea ka lōʻihi o ke kaʻina hana lapaʻau? Mai ka hōʻiliʻili ʻana i nā cell a hiki i ka hoʻokomo ʻana, he mau pule ka manawa maʻamau, a ukali ʻia e nā hana hoʻomau e loiloi ai i ka pane.
Inā ʻoe e ʻimi nei Ka lāʻau lapaʻau CAR-T no ka maʻi ʻaʻai hepatic, ua mākaukau kā mākou hui ma Bioocus e kūkākūkā pehea e hoʻohui ai i kāu hoʻolālā mālama. E kiʻi i kahi kūkākūkā e nānā hou i kāu mau koho me ke alakaʻi i hoʻokumu ʻia ma nā hōʻike—hoʻomaka kāu huakaʻi i ka hoʻokele maikaʻi me nā koho i naʻauao ʻia.
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.